Les Ulis, France

Edith Begin

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Edith Begin in Immunoglobulin Stabilization

Introduction: Edith Begin, a dedicated inventor based in Les Ulis, France, has made significant contributions to the field of biotechnology with her innovative work. With a total of three patents to her name, she is particularly recognized for her advancements in stabilizing immunoglobulin G compositions.

Latest Patents: Among her latest patents, Edith's work includes a method for stabilizing an immunoglobulin G composition in liquid form. This invention involves a stabilizing formulation that comprises a sugar alcohol, glycine, and a non-ionic detergent. It is specifically designed for the stabilization of immunoglobulin G compositions in both liquid and lyophilized forms. Additionally, her patent further details an immunoglobulin G composition that incorporates this stabilizing formulation, enhancing its viability and effectiveness.

Career Highlights: Edith Begin is associated with Laboratoire Français du Fractionnement et des Biotechnologies, a company renowned for its innovative approaches in the field of biotechnologies. Her work has underscored the importance of stability in immunoglobulin formulations, contributing positively to the medical and biopharmaceutical sectors.

Collaborations: Throughout her career, Edith has collaborated with esteemed colleagues, including Annie Bardat and Nassirah Khandoudi. These collaborations have enabled her to enhance her research and implement her innovative ideas effectively, pushing the boundaries of what is possible in immunoglobulin stabilization.

Conclusion: Edith Begin's innovative patents and her dedication to biotechnology position her as a leading figure in her field. Her contributions not only improve the stability of valuable immunoglobulin products but also pave the way for further research and development in biopharmaceutical applications. As she continues her work at Laboratoire Français du Fractionnement et des Biotechnologies, the impact of her innovations will undoubtedly resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…